WebHelsinn is a Swiss Biopharmaceutical Group with an innovative R&D pipeline in cancer supportive care and oncology therapeutics, strategically investing in a fully integrated … About Us “When my father, Dr. Gabriele Braglia, founded Helsinn in 1976, he … Helsinn's Business Strategy Since its foundation, the Helsinn Group has had a … Overview Board and Executive Management Helsinn Group Worldwide … That’s why over the past five years we’ve reinvested over 20% of our revenues … CHIASSO, Switzerland and LUGANO, Switzerland – November 28, 2024 – … Patient safety is a priority for Helsinn. We are committed to collect, analyze and … Manufacturing. We’re committed to quality; it’s one of the core values that define … Helsinn operates a unique integrated licensing business model, achieving … Web5 sep. 2024 · AMAL Therapeutics raises €8 million (CHF 8.8 million) in first closing of Series B financing round. Financing round co-led by Boehringer Ingelheim Venture Fund, BioMedPartners and Helsinn ...
Cancer Supportive Care - Helsinn
WebRoberto De Ponti. Position: Board Advisor. Roberto is Managing Director and General Partner of 3B Future Health Ventures sarl. Prior to this, Roberto was Head of Corporate Business Development at Helsinn. Roberto has held several Senior Director positions in various pharmaceutical companies including Pfizer, Indena, Pharmacia & Upjohn, … Web1 jun. 2024 · BridgeBio and Helsinn Group’s affiliate, Helsinn Therapeutics (U.S.), Inc., will be jointly responsible for commercialization activities in the U.S. and will share U.S. profits and losses on an equal basis. Helsinn Group will have exclusive commercialization rights on infigratinib outside of the U.S., excluding China, Hong Kong and Macau. cory total
HELSINN THERAPEUTICS U.S. Revenue, Growth & Competitor …
WebSupport. Americas +1 212 318 2000. EMEA +44 20 7330 7500. Asia Pacific +65 6212 1000. WebBrand Director, VALCHLOR at Helsinn Therapeutics (U.S.), Inc. Ralph Saraceno Senior Oncology Sales Representative at Helsinn Therapeutics, Oncology/Rare Disease … WebHelsinn Therapeutics (US) Inc. Mar 2024 - Present4 years 1 month Iselin, NJ • Lead in the creation of strategic, operational and financial automated visualization dashboards with key... cory toth